First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.75 EUR -0.72% Market Closed
Updated: May 18, 2024

BRAIN Biotech AG
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BRAIN Biotech AG
Long-Term Debt Peer Comparison

Comparables:
WCH
EVK
1COV
ACT
SY1

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Long-Term Debt
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Long-Term Debt
€1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Evonik Industries AG
XETRA:EVK
Long-Term Debt
€3.5B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
19%
Covestro AG
XETRA:1COV
Long-Term Debt
€2.8B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Long-Term Debt
€52m
CAGR 3-Years
-2%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Long-Term Debt
€2.5B
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
19%

See Also

What is BRAIN Biotech AG's Long-Term Debt?
Long-Term Debt
0 EUR

Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Long-Term Debt amounts to 0 EUR.